These findings are consistent with a previous study that revealed that C4 alleviates airway hyperresponsiveness and eosinophilic increases in patients with allergic asthma through HDAC inhibition and a process independent of GPR41 and GPR43 receptor activation (125). The gene discussed is HDAC9; the disease is allergic asthma.